NewsRoom Articles - Page 808 of 1256

TuesdayDec 04, 2018 3:30 pm

xG Technology, Inc. (NASDAQ: XGTI) Starts Presentation at LD Micro Main Event

xG Technology (NASDAQ: XGTI) designs, develops, and delivers advanced wireless communications solutions worldwide. The company’s IMT and Vislink brands are well-known in live video communications and trusted suppliers in the broadcast, sports, entertainment, law enforcement, public safety and defense markets. In the broadcast, sports and entertainment sectors, IMT and Vislink provide high-definition communication links to reliably capture, transmit and manage live event footage. In the law enforcement, public safety & defense markets, IMT and Vislink provide secure video communications and mission-critical solutions to local, national and international agencies and organizations. For more information, visit the company’s websites at www.IMT-Solutions.com and…

TuesdayDec 04, 2018 3:30 pm

Hamilton Thorne Ltd (HTL.V) Starts Presentation at LD Micro Main Event

Hamilton Thorne Ltd. (TSX-V: HTL) is a global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. For more information, visit the company's website at www.hamiltonthorne.ltd. About NetworkNewsWire NetworkNewsWire (NNW) is a…

TuesdayDec 04, 2018 3:30 pm

MGX Minerals Inc. (XMG.CN) (MGXMF) Starts Presentation at LD Micro Main Event

MGX Minerals Inc. (XMG.CN) (OTC: MGXMF) is a diversified Canadian resource and technology company with interests in global advanced material, energy and water assets. Established in 2012, MGX Minerals has grown from its roots in conventional mining into a diversified clean energy and mining technology company. Through direct research and development, strategic partnerships and acquisition of promising assets and technologies in battery commodities, extraction processes, and clean tech for the oil, gas and mining sectors, MGX is fueling tomorrow’s clean energy economy. For more information, visit the company's website at www.mgxminerals.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

TuesdayDec 04, 2018 3:30 pm

NewBridge Global Ventures, Inc. (NBGV) Starts Presentation at LD Micro Main Event

NewBridge Global Ventures (OTCQB: NBGV) is engaged in acquiring and operating a vertically integrated portfolio of California cannabis and hemp companies. The company believes that by concentrating on compliance, industry best practices, standardization and corporate governance, it will be directly positioned for rapid sales growth in the legal California cannabis and industrial hemp Industry. For more information, visit www.NewBridgegv.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial…

TuesdayDec 04, 2018 3:30 pm

Nemus Bioscience, Inc. (NMUS) Starts Presentation at LD Micro Main Event

Nemus Bioscience (OTCQB: NMUS) is a biopharmaceutical company focused on the discovery, development and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in global markets. Headquartered in Long Beach, California, NMUS’ strategy is to explore — alone or with corporate partners — the use of proprietary biosynthetic compounds. With proprietary technology licensed from the University of Mississippi, the company is engaged in developing novel ways to deliver cannabinoid-based drugs for specific indications with the goal of optimizing the clinical effects of such drugs while limiting potential adverse events. The company is led by a qualified team of executives with…

TuesdayDec 04, 2018 3:00 pm

Arch Therapeutics, Inc. (ARTH) Starts Presentation at LD Micro Main Event

Arch Therapeutics, Inc. (OTC: ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's development stage product candidates include AC5™ Topical Gel and AC5™ Surgical Hemostatic Device. For more information, visit the company's website at www.archtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach…

TuesdayDec 04, 2018 3:00 pm

Predictive Technology Group, Inc. (PRED) Starts Presentation at LD Micro Main Event

Predictive Technology Group, (OTC: PRED) aims to revolutionize patient care through predictive data analytics, novel gene-based diagnostics and companion therapeutics through its subsidiaries Predictive Therapeutics, Predictive Biotech, Predictive Diagnostics and Predictive Laboratories. These subsidiaries are focused on endometriosis, scoliosis, degenerative disc disease and human cell and tissue products. The subsidiaries use genetic and other information as cornerstones in the development of new diagnostics that assess a person’s risk of illness and therapeutic products designed to identify, prevent and treat diseases more effectively. For more information, visit the company's website at www.predtechgroup.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

TuesdayDec 04, 2018 3:00 pm

BirchBioMed, Inc. Starts Presentation at LD Micro Main Event

BirchBioMed, Inc. is a biomedical company focused on the commercialization, clinical evaluation and development of proprietary anti-scarring drugs, autoimmune therapeutics/therapies and novel strategies for transplantation. As a University of British Columbia (UBC) spinoff, BirchBioMed holds the exclusive, worldwide pharmaceutical license for two of UBC’s most highly regarded therapeutics, which the university considers to be major medical breakthroughs in the treatment of scarring and certain autoimmune diseases, including Type 1 diabetes and alopecia. For more information, visit the company's website at www.birchbiomed.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network…

TuesdayDec 04, 2018 3:00 pm

Vivakor, Inc. (VIVK) Starts Presentation at LD Micro Main Event

Vivakor (OTC: VIVK) is a technology and asset acquisition company with a primary focus in the area of natural resources. Vivakor’s corporate mission is to create, acquire and accumulate distinct assets, intellectual properties (“IP”), and exceptional technologies that produce solid returns to its valued shareholders and partners. The company currently focuses on bitumen extraction from shallow, oil-laden areas in Eastern Utah and petroleum-based remediation projects globally. From the point of product or technology conception, or through acquisition, development and commercialization, Vivakor expects to have strategic partners, joint ventures or licensing arrangements in place for many of its products in order…

TuesdayDec 04, 2018 3:00 pm

Citius Pharmaceuticals, Inc. (CTXR) Starts Presentation at LD Micro Main Event

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously approved active pharmaceutical ingredients. Citius seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs. By using previously approved drugs with substantial safety and efficacy data, the company seeks to reduce risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches.…